245 related articles for article (PubMed ID: 18755722)
1. Haemoglobin A1c analysis in the management of patients with diabetes: from chaos to harmony.
Berg AH; Sacks DB
J Clin Pathol; 2008 Sep; 61(9):983-7. PubMed ID: 18755722
[TBL] [Abstract][Full Text] [Related]
2. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds.
Zoungas S; Chalmers J; Ninomiya T; Li Q; Cooper ME; Colagiuri S; Fulcher G; de Galan BE; Harrap S; Hamet P; Heller S; MacMahon S; Marre M; Poulter N; Travert F; Patel A; Neal B; Woodward M;
Diabetologia; 2012 Mar; 55(3):636-43. PubMed ID: 22186981
[TBL] [Abstract][Full Text] [Related]
3. Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
Hirsch IB
Diabetes Care; 2015 Aug; 38(8):1610-4. PubMed ID: 26207054
[TBL] [Abstract][Full Text] [Related]
4. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range.
Gustavsson CG; Agardh CD
Eur Heart J; 2004 Dec; 25(23):2120-4. PubMed ID: 15571827
[TBL] [Abstract][Full Text] [Related]
5. Aiming for better glucose control: is HbA(1c) of 7% the 'holy grail'? The clinical approach or seven clinical questions about 7.
Koren S; Rapoport MJ
Diabetes Metab Res Rev; 2014 Jul; 30(5):346-9. PubMed ID: 24510443
[TBL] [Abstract][Full Text] [Related]
6. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.
Currie CJ; Peters JR; Tynan A; Evans M; Heine RJ; Bracco OL; Zagar T; Poole CD
Lancet; 2010 Feb; 375(9713):481-9. PubMed ID: 20110121
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
[TBL] [Abstract][Full Text] [Related]
8. Area-under-the-HbA1c-curve above the normal range and the prediction of microvascular outcomes: an analysis of data from the Diabetes Control and Complications Trial.
Maple-Brown LJ; Ye C; Retnakaran R
Diabet Med; 2013 Jan; 30(1):95-9. PubMed ID: 22937915
[TBL] [Abstract][Full Text] [Related]
9. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.
Bennett CM; Guo M; Dharmage SC
Diabet Med; 2007 Apr; 24(4):333-43. PubMed ID: 17367307
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity and glycemic control in patients with type 2 diabetes.
El-Kebbi IM; Ziemer DC; Cook CB; Miller CD; Gallina DL; Phillips LS
Arch Intern Med; 2001 May; 161(10):1295-300. PubMed ID: 11371257
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
[TBL] [Abstract][Full Text] [Related]
12. Classification of variant forms of haemoglobin according to the ratio of glycated haemoglobin to glycated albumin.
Miyazaki A; Kohzuma T; Kasayama S; Koga M
Ann Clin Biochem; 2012 Sep; 49(Pt 5):441-4. PubMed ID: 22715294
[TBL] [Abstract][Full Text] [Related]
13. Use of the Bayer DCA 2000+ for the measurement of glycated haemoglobin in a remote Australian Aboriginal community.
Shemesh T; Piers LS; O'Dea K
Ann Clin Biochem; 2003 Sep; 40(Pt 5):566-8. PubMed ID: 14503997
[TBL] [Abstract][Full Text] [Related]
14. Inequalities in glycaemic control in patients with Type 2 diabetes in primary care.
Bebb C; Kendrick D; Stewart J; Coupland C; Madeley R; Brown K; Burden R; Sturrock N
Diabet Med; 2005 Oct; 22(10):1364-71. PubMed ID: 16176198
[TBL] [Abstract][Full Text] [Related]
15. Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study.
Calvert MJ; McManus RJ; Freemantle N
Br J Gen Pract; 2007 Jun; 57(539):455-60. PubMed ID: 17550670
[TBL] [Abstract][Full Text] [Related]
16. Glycemic Variability and Diabetes Complications: Does It Matter? Simply Put, There Are Better Glycemic Markers!
Bergenstal RM
Diabetes Care; 2015 Aug; 38(8):1615-21. PubMed ID: 26207055
[TBL] [Abstract][Full Text] [Related]
17. Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus.
Kilpatrick ES
J Clin Pathol; 2008 Sep; 61(9):977-82. PubMed ID: 18755721
[TBL] [Abstract][Full Text] [Related]
18. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
19. [Changes in weight and diabetes compensation (HbA(1c)) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBY-I study (observations lasting 3 to 12 months)].
Perusicová J; Haladová I; Pit'hová P; Acsová D; Belobrádková J; Belzová A; Berková K; Dolezalová B; Dvoráková H; Hejnicová K; Hudcová M; Kallmünzerová D; Krejsová Z; Markofová G; Müllerová H; Owen K; Pelikánová M; Raclavská L; Racická E; Skarpová O; Váchová A; Veselá A; Vyoralos J; Broz J; Edelsberger T; Honka M; Hrdina T; Chmura P; Tosovský J
Vnitr Lek; 2013 Mar; 59(3):165-71. PubMed ID: 23713182
[TBL] [Abstract][Full Text] [Related]
20. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
